N@N

FORT LAUDERDALE, Fla.--([ BUSINESS WIRE ])--Imaging Diagnostic Systems, Inc., (OTCBB:IMDS), a pioneer in laser optical breast imaging, announced today that it is exhibiting at the world's premier medical meeting and featuring its CT Laser breast imaging device at the 97th annual Radiological Society of North America (RSNA) Scientific Assembly meeting in Chicago, Illinois November 27-December 2nd.

"RSNA provides an excellent venue for IDSI to present our CTLM system which has been recently recognized as Diffuse Optical Tomography (DOT) to the national and international markets"

The RSNA offers unparallel education and professional development for medical professionals from all over the world while showcasing cutting-edge medical imaging technology and services. It provides a great opportunity to network with other medical professionals; trade products and services, build and strengthen relationships nationally and internationally with attendees from 100 countries from around the world in one location.

"RSNA provides an excellent venue for IDSI to present our CTLM system which has been recently recognized as Diffuse Optical Tomography (DOT) to the national and international markets," commented Linda Grable/ CEO and Chairman of Imaging Diagnostic Systems, Inc.

Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. CT Laser Mammography (CTLM) is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and shows the process of angiogenesis, which usually accompanies tumor growth. CTLM system has received international certifications and licenses from the European CE mark, CMDCAS Canadian Health screening, China SFDA, India, UL, and ISO 13485.

For more information, visit our website: [ www.imds.com ]

As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future, anticipated, or projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Companyas filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.